Home > Cardiology > ESC 2020 > COVID and Cardiovascular Disease > The Yale COVID-19 Cardiovascular Registry

The Yale COVID-19 Cardiovascular Registry

Presented By
Dr Manan Pareek, Yale University School of Medicine, USA
ESC 2020
Yale COVID-19 Cardiovascular Registry
Preliminary prospective cohort data from the Yale COVID-19 Cardiovascular Registry showed that at least 40% of patients hospitalised with verified COVID-19 had a high cardiovascular (CV) risk at baseline, including a high prevalence of diabetes and hypertension. Patients with CV risk in the Yale registry cohort had high mortality rates and CV complications; about 1 in 5 patients died, 2 in 5 experienced a CV event, and 1 in 5 required mechanical ventilation [1]. Dr Manan Pareek (Yale University School of Medicine, USA) presented the data, which was intended to supplement the sparse body of evidence suggesting that patients with a high CV risk or disease burden tend to be more vulnerable during SARS-CoV-2 infection. The aim of the analysis was to determine the prevalence of CV risk factors, established CV disease, and associated medications. Additionally, they sou...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on